publication date: Jul. 19, 2019
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.
Most Americans receive cancer treatment close to home, at community hospitals or in community oncologists’ offices. And based on patient satisfaction surveys, most Americans are very happy with the care they receive.
Women who underwent minimally invasive radical hysterectomies had twofold the rate of death and cervical cancer recurrence, compared to women who received open radical hysterectomies, according to a large retrospective study conducted by researchers at the University of Toronto.
A retrospective study of nearly 1,000 women who underwent surgery for early-stage cervical cancer showed that minimally invasive radical hysterectomy was associated with double the rate of death and recurrence—at a population level over 10 years in Ontario, Canada.
- Biden Cancer Initiative suspends operations
- Callender named president and CEO of Memorial Hermann Health System
- Anixa Biosciences + Cleveland Clinic partner for breast cancer vaccine
- FDA publishes draft guidance for developing GnRH analogues
The Snowdome Foundation and Leukaemia Foundation joined with the Leukemia & Lymphoma Society to fund four blood cancer research projects with Australian researchers through the LLS Translational Research Program.
- Paige.AI publishes study on clinical-grade pathology
- Elios announces positive data from phase IIb study of vaccine in melanoma
- INT230-6 induces immune activation, Intensity Therapeutics and NCI report
- Study shows spatial biology needed for predicting immuno-oncology response
- Rise in early onset colorectal cancer not aligned with screening trends
- Hurricane disasters associated with poorer outcomes for radiotherapy
- Biomarker-guided strategy has potential for liver cancer treatment
- Australian regulator conditionally OKs expanded uses for Keytruda